[Combined (surgical and drug) therapy of lung cancer].
The paper deals with an evaluation of the immediate and end results as well as the rates of lung tumor progression in the course of surgical and combined therapy including different schedules of long-term administration of preparation CCNU. Combined therapy was shown to be followed by a longer remission and survival, as compared with cancer patients in control. The said effect was particularly pronounced is cases of squamous-cell carcinoma and in patients treated with levomycetin.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000601:surgery; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000601:surgery; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000601:surgery; D002701:Chloramphenicol / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000601:surgery*
D002701:Chloramphenicol; D008130:Lomustine
Kombinirovannoe (khirurgicheskoe i lekarstvennoe) lechenie bol'nykh rakom legkogo.